Patient with pulmonary idiopathic fibrosis developed colitis due to treatment indicated for this affection
Belinda Z. Burgos, Katherine Trujillo Useche
Agencia Latina de Noticias Medicina y Salud Pública
This woman will receive his treatment for his illness and develop a complicated and desperate complication in literature.
And there is a female 69 years diagnosed with pulmonary idiopathic fibrosis (FPI) has initiated its treatment with what Nintedanib knows and time has begun to initiate an increase in hepatic enzymes
Nintedanib is a drug that is used to treat this catastrophic affection, which helps to reverse the progress of the disease, giving the deep tissue of its pulses and scarring.
It is hoped that this tee will be able to withstand a great deal of adverse conditions, and that it will be possible for it to recover without oxygen. The cause of the FPI includes ambient contaminants, some drugs, connective tissue diseases or interstitial pulmonary disease and genetic factors.
“Causes of hepatic elevation are the cause of diminishing the dose of the drug and then one year after treatment the production of a severe diarrhea”, explained Doctora González.
The patient performs a colonoscopy that shows that he has erythema and irregular images throughout the colon. The median biopsies are performed consistently with a colitis persistent by the treatment being used.
Colitis is characterized by inflammation of the internal colon.
“Because of a complicated case where the patient does not want to be treated then he must have a respiratory major improving his quality of life. “It started a treatment with low doses of trinisol diary steroids during the week and it’s going to reduce colitis’s symptoms,” he said.
It was added that in the literature alone he described the cases of this type of complications associated with this treatment.
“In the literature alone, there are many cases in which it has been reported that it is very rare for a patient to develop colitis because of treatment and that is the only treatment used for pulmonary fibrosis,” said Dra.
“Literature is based more on the need to discontinue treatment for this case, which is why we do not have another type of medicine to be able to provide a better quality of life to the patient,” the doctor concludes.